What Happened?
Ann Arbor, MI-based ONL-Therapeutics Appointed David Esposito as President and Chief Executive Officer
About the Company
ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal disease and conditions.
About the Person
David Esposito is President and Chief Executive Officer at ONL Therapeutics. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile